165 related articles for article (PubMed ID: 16989636)
1. The potential role of fowlpox virus in rational vaccine design.
Beukema EL; Brown MP; Hayball JD
Expert Rev Vaccines; 2006 Aug; 5(4):565-77. PubMed ID: 16989636
[TBL] [Abstract][Full Text] [Related]
2. Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.
Skinner MA; Laidlaw SM; Eldaghayes I; Kaiser P; Cottingham MG
Expert Rev Vaccines; 2005 Feb; 4(1):63-76. PubMed ID: 15757474
[TBL] [Abstract][Full Text] [Related]
3. Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.
Bejon P; Peshu N; Gilbert SC; Lowe BS; Molyneux CS; Forsdyke J; Lang T; Hill AV; Marsh K
Clin Infect Dis; 2006 Apr; 42(8):1102-10. PubMed ID: 16575727
[TBL] [Abstract][Full Text] [Related]
4. Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNgamma or IL-12.
Dale CJ; De Rose R; Wilson KM; Croom HA; Thomson S; Coupar BE; Ramsay A; Purcell DF; Ffrench R; Law M; Emery S; Cooper DA; Ramshaw IA; Boyle DB; Kent SJ;
Vaccine; 2004 Nov; 23(2):188-97. PubMed ID: 15531036
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy with poxvirus vectors.
Moroziewicz D; Kaufman HL
Curr Opin Mol Ther; 2005 Aug; 7(4):317-25. PubMed ID: 16121697
[TBL] [Abstract][Full Text] [Related]
6. Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials.
Coupar BE; Purcell DF; Thomson SA; Ramshaw IA; Kent SJ; Boyle DB
Vaccine; 2006 Feb; 24(9):1378-88. PubMed ID: 16257479
[TBL] [Abstract][Full Text] [Related]
7. Canarypox and fowlpox viruses as recombinant vaccine vectors: a biological and immunological comparison.
Zanotto C; Pozzi E; Pacchioni S; Volonté L; De Giuli Morghen C; Radaelli A
Antiviral Res; 2010 Oct; 88(1):53-63. PubMed ID: 20643163
[TBL] [Abstract][Full Text] [Related]
8. Lessons for AIDS vaccine development from non-AIDS vaccines.
Clements-Mann ML
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S197-203. PubMed ID: 9814944
[TBL] [Abstract][Full Text] [Related]
9. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
10. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18.
Shen G; Jin N; Ma M; Jin K; Zheng M; Zhuang T; Lu H; Zhu G; Jin H; Jin M; Huo X; Qin X; Yin R; Li C; Li H; Li Y; Han Z; Chen Y; Jin M
Vaccine; 2007 May; 25(21):4193-202. PubMed ID: 17418456
[TBL] [Abstract][Full Text] [Related]
11. A review of vaccine research and development: the human immunodeficiency virus (HIV).
Girard MP; Osmanov SK; Kieny MP
Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
[TBL] [Abstract][Full Text] [Related]
12. Recombinant fowlpox virus vaccines for poultry.
Boyle DB; Heine HG
Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)(5):391-7. PubMed ID: 8270268
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of immune effects of fowlpox vaccine strains and field isolates.
Wang J; Meers J; Spradbrow PB; Robinson WF
Vet Microbiol; 2006 Aug; 116(1-3):106-19. PubMed ID: 16650660
[TBL] [Abstract][Full Text] [Related]
14. [HIV/AIDS vaccines: heading for new vaccine approaches?].
Girard MP
Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
[TBL] [Abstract][Full Text] [Related]
15. Recombinant fowlpox virus elicits transient cytotoxic T cell responses due to suboptimal innate recognition and recruitment of T cell help.
Diener KR; Lousberg EL; Beukema EL; Yu A; Howley PM; Brown MP; Hayball JD
Vaccine; 2008 Jul; 26(29-30):3566-73. PubMed ID: 18541346
[TBL] [Abstract][Full Text] [Related]
16. Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18.
Ma M; Jin N; Shen G; Zhu G; Liu HJ; Zheng M; Lu H; Huo X; Jin M; Yin G; Ma H; Li X; Ji Y; Jin K
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):1-7. PubMed ID: 17706296
[TBL] [Abstract][Full Text] [Related]
17. Funding support lacking in search for HIV vaccine.
AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091
[TBL] [Abstract][Full Text] [Related]
18. [New advances in clinical trials of cancer vaccines].
Peng F; Wei YQ
Ai Zheng; 2006 Aug; 25(8):1059-62. PubMed ID: 16965694
[TBL] [Abstract][Full Text] [Related]
19. Canarypox and fowlpox viruses as recombinant vaccine vectors: an ultrastructural comparative analysis.
Pacchioni S; Volonté L; Zanotto C; Pozzi E; De Giuli Morghen C; Radaelli A
Arch Virol; 2010 Jun; 155(6):915-24. PubMed ID: 20379750
[TBL] [Abstract][Full Text] [Related]
20. HIV vaccine efficacy trials: towards the future of HIV prevention.
Kim D; Elizaga M; Duerr A
Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
